SOLARANSENovember 05, 2025

Solara Active Pharma Sciences Limited

241words
1turns
0analyst exchanges
0executives
Speaking time
Corporate Office
1
Opening remarks
Corporate Office
Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 47406700 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in November 05, 2025 The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540, 890202 The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: SOLARA, SOLARAPP1 Dear Sir / Madam, Subject: Audio recordings of Q2 of FY26 earnings call conducted on November 05, 2025 for the quarter and half year ended September 30, 2025 Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q2 of FY26 Earnings Call held on November 05, 2025, on our Company’s website under the heading Investor relatio
← All transcriptsSOLARA stock page →